Germán Novoa Heckel

Germán Novoa Heckel

Auto-generated profile, based on publicly available information

Germán Novoa Heckel

National Autonomous University of Mexico (UNAM), University Bioethics Program, Mexico City, Mexico.

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2019 in BMC Medical Ethics
Verified
Journal Article
Open access
PDF file
NGNovoa-Heckel Germán
Novoa-Heckel Germán
BRBernabe Rosemarie
Bernabe Rosemarie
The exportation of unethical practices to low- and middle-income countries (“Ethics Dumping”) has been conceived as a prevalent practice which needs to be examined more closely. Such a practice might point towards the exploitation of vulnerable population groups. We conducted a survey among Mexican research ethics committee members to explore the issue of ethics dumping in Mexico by understanding how its existence and contributing factors and norms are perceived by these ethics committee members. We designed an exploratory survey based on a five-point Likert scale, following an established, validated and published methodology. The questionnaire included both open close-ended questions. The aspects covered in the questionnaire were introductory questions on the existence of ethical issues; general perception on ethics dumping in Mexico; lack of voluntariness, undue inducement, and therapeutic misconception as exploitation risks; existence of exploitative practices; norms facilitating ethics dumping; acceptable levels of benefit to Mexico; boundaries of ethics dumping. The survey was administered to a sample of research ethics committee members from public and private Mexican hospitals in 2016. Most of the ethics committee members believed clinical trials are generally ethically sound, though almost a majority think that ethics dumping is a common occurrence and that it is a serious issue. Most agree that ethics dumping needs to be addressed. They also identified other issues such as ethical issues related to patient participation and ethics committees. Further, most committee members agree that undue inducement and therapeutic misconception affect voluntariness, and that both individuals and communities receive appropriate benefits. From the perspective of Mexican research ethics committee members, ethics dumping commonly exists in Mexican clinical trials, as well as several related issues such as ethical issues on patient participation and ethics committees, as well as voluntariness issues. Further, most members believed these issues need to be addressed. However, most were also of the opinion that clinical trials are generally ethically compliant. This points to the need for further studies on the reasons for these perspectives.

29 June 2018 in Revista Digital Universitaria
Verified
Journal Article
Closed access
GHGermán Novoa Heckel
Germán Novoa Heckel
P(Programa Universitario de Bioética Universidad Nacional Autónoma de México (Unam)
Programa Universitario de Bioética Universidad Nacional Autónoma de México (Unam)

1 April 2025 in Medicina y Ética
Verified
Journal Article
Open access
JTJonathan Tipán-Barros
Jonathan Tipán-Barros
JFJennifer Freire-Ochoa
Jennifer Freire-Ochoa
GNGerman Novoa-Heckel
German Novoa-Heckel
La evidencia disponible demuestra que los estudiantes de medicina están prematuramente relacionados con la publicidad de medicamentos. Esta relación genera un fenómeno denominado: “socialización”, en donde los estudiantes cooperan naturalmente con la industria farmacéutica. Por consiguiente, el objetivo de la presente revisión es indagar sobre la socialización como origen de la actitud positiva frentea la publicidad de medicamentos durante la práctica profesional. A través de una revisión bajo metodología prisma se analizó la literatura académica en inglés y español desde enero de 2019 hasta junio de 2024, obteniendo tres situaciones emergentes: 1) impacto negativo de la publicidad de medicamentos al sistema de salud; 2) socialización en los estudiantes de medicina; y, 3) carentes políticas regulatorias universitarias. Se concluye que la socialización genera actitud positiva para la publicidad de medicamentos durante la formación médica y en el ejercicio profesional.